Peter Meintjes
Chief Executive Officer bei PACIFIC EDGE LIMITED
Vermögen: 19 625 $ am 31.03.2024
Profil
Peter Meintjes is currently the Chief Executive Officer at Pacific Edge Ltd.
Prior to this, he was the Chief Executive Officer at Omixon Biocomputing Kft.
He received his doctorate degree from Auckland University in 2008 and also completed his undergraduate and graduate degrees at Auckland University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PACIFIC EDGE LIMITED
0,05% | 25.10.2023 | 386 016 ( 0,05% ) | 19 625 $ | 31.03.2024 |
Aktive Positionen von Peter Meintjes
| Unternehmen | Position | Beginn |
|---|---|---|
| PACIFIC EDGE LIMITED | Chief Executive Officer | 17.01.2022 |
Ehemalige bekannte Positionen von Peter Meintjes
| Unternehmen | Position | Ende |
|---|---|---|
Omixon Biocomputing Kft
 Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Chief Executive Officer | 20.04.2020 |
Ausbildung von Peter Meintjes
| Auckland University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PACIFIC EDGE LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Health Technology |
